Behçet's syndrome: Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy

Joseph L. Jorizzo, R. Donald Hudson, Frank C. Schmalstieg, Jerry C. Daniels, Prapand Apisarnthanarax, John C. Henry, Emilio Gonzalez, Yukinobu Ichikawa, Tito Cavallo

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Immune regulatory dysfunction, circulating immune complexes (CIC), and polymorphonuclear (PMN) cell migration were investigated in patients with Behçet's syndrome. Six patients meeting rigorous clinical criteria were evaluated. Only one patient showed evidence of immune regulatory dysfunction (increased T4/T8 ratio). Although Clq binding and Raji cell assays for CIC yielded positive results in only one of five patients, all five patients had in vivo “histamine trap test” evidence of CIC (all controls had normal results). Sera from all Behçet's syndrome patients increased migration of neutrophils to zymosan-activated serum. Colchicine therapy abolished the enhancing effect of the patient's sera on movement of PMN cells from patients and controls. An immune complex-mediated injury that is followed by an excessive accumulation of PMN cells may lead to the cutaneous lesions and other lesions in Behçet's syndrome. Further evaluation of colchicine therapy is warranted on the basis of these studies.

Original languageEnglish (US)
Pages (from-to)205-214
Number of pages10
JournalJournal of the American Academy of Dermatology
Volume10
Issue number2
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Colchicine
Antigen-Antibody Complex
Neutrophils
Therapeutics
Cell Movement
Serum
CD4-CD8 Ratio
Zymosan
Histamine
Skin
Wounds and Injuries

ASJC Scopus subject areas

  • Dermatology

Cite this

Jorizzo, J. L., Hudson, R. D., Schmalstieg, F. C., Daniels, J. C., Apisarnthanarax, P., Henry, J. C., ... Cavallo, T. (1984). Behçet's syndrome: Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. Journal of the American Academy of Dermatology, 10(2), 205-214. https://doi.org/10.1016/S0190-9622(84)70024-7

Behçet's syndrome : Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. / Jorizzo, Joseph L.; Hudson, R. Donald; Schmalstieg, Frank C.; Daniels, Jerry C.; Apisarnthanarax, Prapand; Henry, John C.; Gonzalez, Emilio; Ichikawa, Yukinobu; Cavallo, Tito.

In: Journal of the American Academy of Dermatology, Vol. 10, No. 2, 1984, p. 205-214.

Research output: Contribution to journalArticle

Jorizzo, JL, Hudson, RD, Schmalstieg, FC, Daniels, JC, Apisarnthanarax, P, Henry, JC, Gonzalez, E, Ichikawa, Y & Cavallo, T 1984, 'Behçet's syndrome: Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy', Journal of the American Academy of Dermatology, vol. 10, no. 2, pp. 205-214. https://doi.org/10.1016/S0190-9622(84)70024-7
Jorizzo, Joseph L. ; Hudson, R. Donald ; Schmalstieg, Frank C. ; Daniels, Jerry C. ; Apisarnthanarax, Prapand ; Henry, John C. ; Gonzalez, Emilio ; Ichikawa, Yukinobu ; Cavallo, Tito. / Behçet's syndrome : Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. In: Journal of the American Academy of Dermatology. 1984 ; Vol. 10, No. 2. pp. 205-214.
@article{a06d431e239244b4bd2cb1b3b5fd8923,
title = "Beh{\cc}et's syndrome: Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy",
abstract = "Immune regulatory dysfunction, circulating immune complexes (CIC), and polymorphonuclear (PMN) cell migration were investigated in patients with Beh{\cc}et's syndrome. Six patients meeting rigorous clinical criteria were evaluated. Only one patient showed evidence of immune regulatory dysfunction (increased T4/T8 ratio). Although Clq binding and Raji cell assays for CIC yielded positive results in only one of five patients, all five patients had in vivo “histamine trap test” evidence of CIC (all controls had normal results). Sera from all Beh{\cc}et's syndrome patients increased migration of neutrophils to zymosan-activated serum. Colchicine therapy abolished the enhancing effect of the patient's sera on movement of PMN cells from patients and controls. An immune complex-mediated injury that is followed by an excessive accumulation of PMN cells may lead to the cutaneous lesions and other lesions in Beh{\cc}et's syndrome. Further evaluation of colchicine therapy is warranted on the basis of these studies.",
author = "Jorizzo, {Joseph L.} and Hudson, {R. Donald} and Schmalstieg, {Frank C.} and Daniels, {Jerry C.} and Prapand Apisarnthanarax and Henry, {John C.} and Emilio Gonzalez and Yukinobu Ichikawa and Tito Cavallo",
year = "1984",
doi = "10.1016/S0190-9622(84)70024-7",
language = "English (US)",
volume = "10",
pages = "205--214",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Behçet's syndrome

T2 - Immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy

AU - Jorizzo, Joseph L.

AU - Hudson, R. Donald

AU - Schmalstieg, Frank C.

AU - Daniels, Jerry C.

AU - Apisarnthanarax, Prapand

AU - Henry, John C.

AU - Gonzalez, Emilio

AU - Ichikawa, Yukinobu

AU - Cavallo, Tito

PY - 1984

Y1 - 1984

N2 - Immune regulatory dysfunction, circulating immune complexes (CIC), and polymorphonuclear (PMN) cell migration were investigated in patients with Behçet's syndrome. Six patients meeting rigorous clinical criteria were evaluated. Only one patient showed evidence of immune regulatory dysfunction (increased T4/T8 ratio). Although Clq binding and Raji cell assays for CIC yielded positive results in only one of five patients, all five patients had in vivo “histamine trap test” evidence of CIC (all controls had normal results). Sera from all Behçet's syndrome patients increased migration of neutrophils to zymosan-activated serum. Colchicine therapy abolished the enhancing effect of the patient's sera on movement of PMN cells from patients and controls. An immune complex-mediated injury that is followed by an excessive accumulation of PMN cells may lead to the cutaneous lesions and other lesions in Behçet's syndrome. Further evaluation of colchicine therapy is warranted on the basis of these studies.

AB - Immune regulatory dysfunction, circulating immune complexes (CIC), and polymorphonuclear (PMN) cell migration were investigated in patients with Behçet's syndrome. Six patients meeting rigorous clinical criteria were evaluated. Only one patient showed evidence of immune regulatory dysfunction (increased T4/T8 ratio). Although Clq binding and Raji cell assays for CIC yielded positive results in only one of five patients, all five patients had in vivo “histamine trap test” evidence of CIC (all controls had normal results). Sera from all Behçet's syndrome patients increased migration of neutrophils to zymosan-activated serum. Colchicine therapy abolished the enhancing effect of the patient's sera on movement of PMN cells from patients and controls. An immune complex-mediated injury that is followed by an excessive accumulation of PMN cells may lead to the cutaneous lesions and other lesions in Behçet's syndrome. Further evaluation of colchicine therapy is warranted on the basis of these studies.

UR - http://www.scopus.com/inward/record.url?scp=0021357555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021357555&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(84)70024-7

DO - 10.1016/S0190-9622(84)70024-7

M3 - Article

C2 - 6371066

AN - SCOPUS:0021357555

VL - 10

SP - 205

EP - 214

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -